1 / 59

OB CASE PRESENTATION

OB CASE PRESENTATION. Zshari Zxilka T. Tanggol Medical Intern Department of Obstetrics and Gynecology August 2010 Preceptor: Dr. Fernandez. General Data. N.A. 31 y/o G3P3 (3003) Married Islam Pasig City. Past Medical History.

jalena
Download Presentation

OB CASE PRESENTATION

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. OB CASE PRESENTATION Zshari Zxilka T. Tanggol Medical Intern Department of Obstetrics and Gynecology August 2010 Preceptor: Dr. Fernandez

  2. General Data • N.A. • 31 y/o G3P3 (3003) • Married • Islam • Pasig City

  3. Past Medical History • No hypertension, diabetes mellitus, bronchial asthma, cancer, thyroid disease • Previous operation: s/p CS III x, Ix for CPD (1997, 2008, 2005) • No known allergies • No history of blood transfusions

  4. Family History • (+) Hypertension – mother • (+) Diabetes Mellitus – mother • No bronchial asthma, heart disease, cancer, thyroid abnormalities

  5. Personal and Social History • Nonsmoker • Non-alcoholic beverage drinker

  6. Menstrual History • Menarche: 12 y/o • Regular • 5 days • 3 pads per day • (-) pain • LMP: June (3rd or 4th week) 2010 • PMP: May 2010

  7. Obstetric History • G3P3 (3003)

  8. Gynecologic and Sexual History • Coitarche: 18 y/o • Sexual Partner: 1 • Sexually active • Family Planning Method: None • (-) Pap smear • (-) use of OCPs • (-) abnormal vaginal discharge

  9. History of Present Illness (+) Right lower quadrant pain, stabbing, nonradiating, 7/10 intensity, intermittent (-) fever, nausea, vomiting (-) vaginal bleeding (-) vaginal discharge (+) Amenorrhea ~5 weeks No consult done nor medications taken 7 days PTA 3 days PTA (+) Recurrence of RLQ pain (+) Associated with minimal vaginal bleeding with passage of blood clots

  10. History of Present Illness (+) Symptoms persisted  Patient sought consult with AMD where ultrasound was done (Zamboanga) which showed, right ovary: 3.9 x 3.7 thin walled anechoic mass 2 days PTA Few hours PTA • (+) Increase in RLQ pain • (+) Generalized weakness • Consult at SLMC where TVS done which showed right adnexal mass highly suggestive of an ectopic gestational sac probably tubal with small leak or rupture • stat gyne laparotomy: ADMISSION

  11. Review of Systems • General: no weight loss, anorexia, easy fatigability • Eye: no visual dysfunction, itchiness, lacrimation or redness • Ears: no dizziness, tinnitus, deafness, discharge or vertigo • Nose: no congestion, no discharge, no hyperemia • Mouth: no lesions or discharges • Neck: no hoarseness or stiffness

  12. Review of Systems • Pulmonary: no dyspnea, no cough • Cardiac: no chest pains, no palpitations, no PND • Vascular: no phlebitis, varicosities, cyanosis • Gastrointestinal: no change in bowel movements, vomiting • Genitourinary: no frequency, urgency, flank pains • Endocrine: no polyuria, polydipsia, polyphagia, heat/cold intolerance

  13. Review of Systems • Musculoskeletal: no joint stiffness, swelling or numbness, • Hematopoietic: no pallor or easy bruisability • Neurologic: no headache, vertigo or seizures • Psychiatric: no anxiety, depression, interpersonal relationship difficulties, illusion, delusion

  14. Physical Examination • Awake, conscious, coherent, ambulatory • Not in cardiorespiratory distress • Vital Signs: 120/80 mmHg, 78 bpm regular, 20 cpm regular, 37.3°C • Weight: 65 kg • Height: 157.48 cms • BMI: 26.21 kg/m2 (Overweight)

  15. Physical Examination • Skin: warm, smooth • Head: normocephalic, normal pattern of distribution • Face: no facial asymmetry • Eyes: pink palpebral conjunctivae, anicteric sclerae, pupils 2-3mm briskly reactive to light • Ears: patent ear canal; tympanic membrane non perforated, pearly white, with intact cone of light, bilateral • Nose: nasal septum midline, pink nasal mucosa, no nasal congestion. • Throat: non-hyperemic tonsillopharyngeal walls

  16. Physical Examination • Neck: supple neck, no masses, no lymphadenopathies • Chest/Lungs: symmetrical chest expansion, no rib retractions, equal tactile and vocal fremitus; clear breath sounds in all lung fields • Breast/Thorax: symmetrical, no palpable masses or tenderness • Heart: adynamicprecordium, normal rate and regular rhythm, apex beat at 5th L ICS-MCL, no heaves, no thrills, no murmurs.

  17. Physical Examination • Abdomen: Flabby, normoactive bowel sounds, tympanitic, soft, (+) direct tenderness on right lower quadrant, no masses palpated • External pelvic examination: No lesions, redness, excoriations, hyper/hypopigmentations • SE: cervix pink, smooth, (+) minimal to moderate vaginal bleeding • IE: Cervix is long, closed; uterus not enlarged, (+) cervical motion tenderness, (+) right adnexal tenderness and fullness, no left adnexal mass or tenderness • Full and equal pulses; No edema, no cyanosis • Neurologic exam: Essentially normal

  18. Subjective Salient Features • 31 y/o G3P3 (3003) • (+) severe stabbing right lower quadrant pain • (+) amenorrhea • (+) minimal vaginal bleeding • (-) abnormal vaginal discharge, urinary or bowel changes • s/p CS III (Ix for CPD) • Sexually active, (-) use of OCP

  19. Objective Salient Features • Conscious, coherent, not in distress • Stable vital signs • Abdomen: Flabby, normoactive bowel sounds, soft, (+) RLQ direct tenderness, no masses palpated • External pelvic examination: No lesions, redness, excoriations, hyper/hypopigmentations • SE: cervix pink, smooth, (+) minimal to moderate vaginal bleeding • IE: Cervix is long, closed; uterus not enlarged, (+) cervical motion tenderness, (+) right adnexal tenderness and fullness, no left adnexal mass or tenderness

  20. differentials • Abortion • Ovarian Cyst • Pelvic Inflammatory Disease • Subchorionic Hemorrhage • Ectopic Pregnancy

  21. Clinical impression • 31 y/o G4P3 (3013) • Ovarian Cyst, Right • Amenorrhea 5-6 weeks R/o Tubal Pregnancy, right • Previous Caesarian Section IIIx, Ix for Cephalopelvic Disproportion (1997, 1998, 2005)

  22. Ectopic pregnancy

  23. Ectopic Pregnancy • Ektopos: (Greek) out of place • Implantation of a fertilized ovum outside the endometrium lining the uterine cavity • Implantation in any other site considered ectopic • Located mostly in the oviducts • Other reported sites are the cervix, uterine cornu, ovaries, abdomen broad ligament, spleen, liver, retroperitoneum and diaphragm

  24. Risk factors: Classification • Mechanical • Functional • Assisted reproduction • Failed contraception

  25. Mechanical Factors • Prevent or retard passage of ovum to uterine cavity • Tubal kinking and narrowing secondary to: • Prior tubal surgery: highest risk (failed tubal ligation, tubal fertility surgery, partial salpingiectomy) • Peritubal adhesions 2o to post-abortal/puerperal infection, appendicitis, endometriosis • Salpingitis (previous ectopic): narrowing/blind pockets • Myomas/adnexal masses

  26. Mechanical factors • Reduced ciliation 2o to infection: PID (Chlamydia trachomatis), Salpingitis • Developmental tubal abnormalities (diverticula, accessory ostia, hypoplasia)

  27. Functional Factors • Altered tubal motility 2o to changes in serum levels of estrogen and progesterone • Progestin only contraceptives • IUD devices with progesterone • Post-ovulatory high dose estrogen • Ovulation induction • Luteal phase defects • Cigarette smoking: nicotine is known to alter tubal motility, ciliary activity or blastocyst implantation • Increasing age

  28. Assisted reproduction • Increased incidence with gamete intra-fallopian transfer (GIFT) and in-vitro fertilization (IVF) techniques (atypical implantations more common)

  29. Failed contraception • With any form of contraceptive, the absolute number of ectopic pregnancies is decreased because pregnancy occurs less often • In some contraceptive failures, however, the relative number of ectopic pregnancies is increased.

  30. Risk factors • Multiple sexual partners • Prior Caesarian section

  31. Epidemiology • Increasing absolute number and rate of ectopic pregnancy • Non-Caucasians > Caucasians • Increased age • 2% of all pregnancies • 10% of all pregnancy-related deaths • Most common cause of maternal mortality in the 1st trimester

  32. Pathophysiology

  33. Sites of Ectopic Implantation: CLASSIFICATION • Tubal (95-96%) • Ampullary (70%) • Isthmic (12%) • Fimbrial (11%) • Cornual and interstitial (2-3%) • Abdominal (1%) • Cervical (<1%) • CS scar (<1%) • Ovarian (3%)

  34. Normal anatomy of fallopian tube

  35. Ectopic pregnancy: CLINICAL PRESENTATION • PAIN. Severe sharp/stabbing or tearing lower pelvic and abdominal pain (95%) • ABNORMAL BLEEDING. Amenorrhea with some degree of vaginal spotting or bleeding (60-80%) • Abdominal and pelvic tenderness (75%) on palpation with or without palpable pelvic mass (20%) • Vasomotor disturbance (vertigo/syncope) with signs of hemodynamic compromise (20%)

  36. Clinical presentation • First trimester uterine changes (25%) • Cervical motion tenderness • Bulging of posterior fornix • CLASSIC CLINICAL TRIAD: Pain, amenorrhea, vaginal bleeding

  37. Ectopic pregnancy: DIAGNOSIS • Complete history and physical examination • Urinary pregnancy tests: positive in 50% to 95%

  38. Ectopic pregnancy: diagnosis • Serum B-hCG • serial values lower than in normal pregnancy • best correlated with ultrasound • in first 6 weeks of normal gestation, serum HCG rises exponentially: doubling time is noted and is relatively constant • doubling time does not occur in gestation destined to abort or are ectopic

  39. Ectopic pregnancy: diagnosis • Serum progesterone (inconclusive 5-25 ng/ml) • A single progesterone measurement can be used to establish with high reliability that there is a normally developing pregnancy: value exceeding 25 ng/mL excludes ectopic pregnancy with 92.5 % sensitivity • Values <5 ng/mL suggest either an intrauterine pregnancy with a dead fetus or an ectopic pregnancy • Has limited clinical utility

  40. Ectopic pregnancy: diagnosis • Novel serum markers under investigation: vascular endothelial growth factor (VEGF), cancer antigen 125 (CA125), creatine kinase, fetal fibronectin, and mass spectrometry-based proteomics

  41. Diagnosis: ultrasonography • Abdominal sonography • Identification of tubal pregnancy products is difficult • Uterine pregnancy usually is not recognized using abdominal sonography until 5 to 6 menstrual weeks or 28 days after timed ovulation • Vaginal sonography • Uterine pregnancy 1 week after missed menses with B-hCG >1500 mIU/ml • Identification of fetal pole within the uterus with FHT

  42. Patient: Transvaginal USG • Normal sized AV uterus w/ no myometrial lesion • Thin nonspecific endometrium (0.60) • Normal right ovary • Corpus luteum cyst (3.0x2.8x2.6cm), left ovary • Inferomedial and adjacent to right ovary is a complex mass with a 1.0cm gestational sac-like structure within (~5weeks and 5days AOG). • Slightly echogenic free fluid in the cul-de-sac ~5.2x1.8x3.5cm, volume 11cc with amorphous echogenic structure suggestive of blood clot • IMPRESSION: right adnexal mass highly suggestive of an ectopic gestation, probably tubal with small leak or rupture

  43. Vaginal color and pulsed doppler ultrasound • Uterine or extrauterine site of vascular color in characteristic placental shape • Ring of fire pattern • High-velocity low impedance flow pattern compatible with placental perfusion • Ectopic pregnancy: “cold” pattern outside uterus

  44. Ectopic pregnancy: diagnosis • Culdocentesis • Laparoscopy

  45. MULTIMODALITY DIAGNOSIS: 5 components Ectopic pregnancies are identified with the combined use of clinical findings along with serum analyte testing and transvaginal sonography. • Transvaginal sonography • Serum B-hCG level—both the initial level and the pattern of subsequent rise or decline • Serum progesterone level • Uterine curettage • Laparoscopy, laparotomy

  46. Ectopic pregnancy: MANAGEMENT • Medical management • Expectant management • Surgical management

  47. MEDICAL managament • Medical therapy (Methotrexate) for the patient who is asympotomatic, motivated and compliant • The single best prognostic indicator of successful treatment of single dose methotrexate is the initial serum B-hCG level • Methotrexate: rapid absorption of placental tissue

More Related